Identify TAVR patients at increased risk of 30-day readmission. Aid in appropriate transition of care upon discharge and post-discharge follow-up.
Patients undergoing transcatheter aortic valve replacement (TAVR) are at a higher risk of recurrent healthcare resource utilization due to multiple comorbidities, frailty, and advanced age. The 30-day all-cause readmission rate has been reported at 15-20%. We have devised a simple tool to identify patients at higher risk of 30-day readmission using the Nationwide Readmissions Databases (from January 2013 to September 2015).
This simple and easy-to-use risk prediction tool may help identify TAVR patients at increased risk of 30-day readmission, and aid in appropriate transition of care upon discharge and post-discharge follow-up.